Key result
A young woman with a history of COVID-19 pneumonia initially diagnosed with pulmonary thromboembolism was found to have a giant sarcoma of the pulmonary valve.
Why the study?
Pulmonary artery and pulmonary valve sarcomas are very rare malignant vascular tumors, and COVID-19 patients carry high risk for thromboembolism complications that can mimic such presentations.
Case Report (n=1)
Pulmonary valve sarcoma is a very rare tumor that can mimic pulmonary thromboembolism, highlighting the need for careful diagnostic imaging even in patients with a history of COVID-19 who are at high risk for thromboembolic complications.
Answers are grounded in this paper and cite their sources.
Pulmonary valve sarcoma may mimic thromboembolism in post-COVID patients; this case extends the differential but remains hypothesis-generating.
Pulmonary artery and pulmonary valve sarcoma are malignant and very rare vascular tumors with aggressive clinical course and very poor outcomes. Patients affected by coronavirus disease of 2019 (COVID-19) are at a higher risk for thromboembolism complication. We describe a young woman with a history of coronavirus pneumonia and progressive dyspnea, hemodynamic disturbance, edema with initial evaluation, and clinical diagnosis of pulmonary thromboembolism. But further imaging study and pathology demonstrated giant sarcoma of pulmonary valve, obstructing pulmonary valve and extending to right ventricular outflow tract and main of pulmonary artery.
No takes yet. Share an insight, caveat, or question.
Jalalian et al. (2021) conducted a case report in Pulmonary valve sarcoma (n=1). COVID-19 was evaluated on Diagnosis of pulmonary valve sarcoma. A young woman with a history of COVID-19 pneumonia initially diagnosed with pulmonary thromboembolism was found to have a giant sarcoma of the pulmonary valve.
Synapse has enriched 10 related papers. Consider them for comparative context: